Constitutively active muscarinic receptors

Life Sciences

Volumn 68, Issue 22-23, 2001, Pages 2511-2516

  Spalding, Tracy A ^a   Burstein, Ethan S ^a  

^a ACADIA PHARMACEUTICALS INC   (United States)

Author keywords

Agonist; Mutagenesis; Structure

Indexed keywords

ACETYLCHOLINE; AMINO ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; MUSCARINIC RECEPTOR; RHODOPSIN;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CELL NUCLEUS; LIGAND BINDING; MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE;

EID: 0035957579     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01046-3     Document Type: Conference Paper

References (28)

1. Yano K, Kohn LD, Saji M, Kataoka N, Okuno A, Cutler GB Jr. Biochem Biophys Res Commun 1996;27:1036-42
2. Robinson PR, Cohen GB, Zhukovsky EA, Oprian DD. 1992 Neuron;9:719-25
3. Fuhrer D, Holzapfel HP, Wonerow P, Scherbaum WA, Paschke RJ. 1997 Clin Endocrinol Metab;82:3885-91
4. Hilf G, Jakobs KH. 1992 Eur J Pharmacol;225:245-52
5. Jakubik J, Bacakova L, el-Fakahany EE, Tucek S. 1995 FEBS Lett;377:275-9
6. Burstein ES, Spalding TA, Brauner-Osborne H, Brann MR. 1995a FEBS Lett;363:261-3
7. Burstein ES, Spalding TA, Brann MR. 1997 Mol Pharmacol;51:312-9.
8. Farrens DL, Altenbach C, Yang K, Hubbell WL, Khorana HG 1996 Science;274:768-70.
9. Javitch JA, Fu D, Liapakis G, Chen J. 1997 J Biol Chem;272:18546-9
10. Spalding TA, Burstein ES, Henderson SC, Ducote KR, Brann MR. 1998 J Biol Chem;273:21563-8
11. Burstein ES, Spalding TA, Brann MR. 1998 J Biol Chem;273:24322-7
12. Burstein ES, Spalding TA, Hill-Eubanks D, Brann MR. 1995 J Biol Chem;270:3141-6
13. Hill-Eubanks D, Burstein ES, Spalding TA, Brauner-Osborne H, Brann MR. 1996 J Biol Chem;271:3058-65
14. Lu ZL, Hulme EC 1999 J Biol Chem;274:7309-15
15. Baranski TJ, Herzmark P, Lichtarge O, Gerber BO, Trueheart J, Meng EC, Iiri T, Sheikh SP, Bourne HR. 1999 J Biol Chem;274:15757-65
16. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. 2000 Science;289:739-45
17. Spalding TA, Burstein ES, Brauner-Osborne H, Hill-Eubanks D, Brann MR. 1995 J Pharmacol Exp Ther;275:1274-9
18. Spalding TA, Burstein ES, Wells JW, Brann MR. 1997 Biochemistry;36:10109-16
19. Kurtenbach E, Curtis CA, Pedder EK, Aitken A, Harris AC, Hulme EC. 1990 J Biol Chem;265:13702-8
20. Spalding TA, Birdsall NJ, Curtis CA, Hulme EC. 1994 J Biol Chem;269:4092-7
21. Fraser CM, Wang CD, Robinson DA, Gocayne JD, Venter JC. 1989 Mol Pharmacol. 1989;36:840-7
22. Page KM, Curtis CA, Jones PG, Hulme EC. 1995 Eur J Pharmacol;289:429-37
23. Wess J, Gdula D, Brann MR. 1991 EMBO J;10:3729-34
24. Ward SD, Curtis CA, Hulme EC. 1999 Mol Pharmacol;56:1031-41
25. Bluml K, Mutschler E, Wess J. 1994 J Biol Chem;269:18870-6
26. Wess J, Nanavati S, Vogel Z, Maggio R. 1993 EMBO J. 12:331-8
27. Jones PG, Curtis CA, Hulme EC. 1995 Eur J Pharmacol;288:251-7
28. Lu ZL, Curtis CA, Jones PG, Pavia J, Hulme EC. 1997 Mol Pharmacol;51:234-41